The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Molecular clustering identifies complement and endothelin induction as early events in a mouse model of glaucoma
Open accessAbstract
Glaucoma is one of the most common neurodegenerative diseases. Despite this, the earliest stages of this complex disease are still unclear. This study was specifically designed to identify early stages of glaucoma in DBA/2J mice. To do this, we used genome-wide expression profiling of optic nerve head and retina and a series of computational methods. Eyes with no detectable glaucoma by conventional assays were grouped into molecularly defined stages of disease using unbiased hierarchical clustering. These stages represent a temporally ordered sequence of glaucoma states. We then determined networks and biological processes that were altered at these early stages. Early-stage expression changes included upregulation of both the complement cascade and the endothelin system, and so we tested the therapeutic value of separately inhibiting them. Mice with a mutation in complement component 1a (C1qa) were protected from glaucoma. Similarly, inhibition of the endothelin system with bosentan, an endothelin receptor antagonist, was strongly protective against glaucomatous damage. Since endothelin 2 is potently vasoconstrictive and was produced by microglia/macrophages, our data provide what we believe to be a novel link between these cell types and vascular dysfunction in glaucoma. Targeting early molecular events, such as complement and endothelin induction, may provide effective new treatments for human glaucoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Indeed, in a mouse model of glaucoma, a neurodegenerative disease associated with RGC loss and gliosis, C1q and C3 are highly upregulated and deposited on retinal synapses and C1q deficiency or microglial ‘inactivation’ with minocycline provide significant neuroprotection (Howell et al., 2011; Steele et al., 2006; Stevens et al., 2007).”
From Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner (2012) · cites this paper as Howell et al., 2011
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692
KEGG for linking genomes to life and the environment
Kanehisa, M. I., Araki, M., Goto, S., Hattori, M., Hirakawa, M., Itoh, M., Katayama, T., Kawashima, S., Okuda, S., Tokimatsu, T., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm882 · Cited by 6,828
affy—analysis of Affymetrix GeneChip data at the probe level
Gautier, L., Cope, L., Bolstad, B. M., & Irizarry, R. A. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg405 · Cited by 5,221
The Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313
Self-citationCahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129
Self-citationNumber of people with glaucoma worldwide.
Quigley, H. A. (1996) · British Journal of Ophthalmology · doi:10.1136/bjo.80.5.389 · Cited by 3,054
What is principal component analysis?
Ringnér, M. (2008) · Nature Biotechnology · doi:10.1038/nbt0308-303 · Cited by 2,407
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557
Microglia in neurodegenerative disease
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.17 · Cited by 1,543
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J. (1998) · Nature Genetics · doi:10.1038/ng0598-56 · Cited by 1,434
Flagged first, then by citations
Research works printed but not linked: 7
- Rolim de Moura, 2007, Cochrane Database Syst Rev., 2007, CD003919
- Anderson, 1974, Invest Ophthalmol., 13, 771
- Quigley, 1977, Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol., 83, 755
- Quigley, 1976, Invest Ophthalmol., 15, 606
- Quigley, 1980, Invest Ophthalmol Vis Sci., 19, 137
- Quigley, 1980, Invest Ophthalmol Vis Sci., 19, 505
- John, 1997, Invest Ophthalmol Vis Sci., 38, 249
Cited by
Sorted by citations
Items 201–300 of 479
Immunomodulation as a Neuroprotective Strategy for Glaucoma Treatment
Barış, M. E., & Tezel, G. (2019) · Current Ophthalmology Reports · doi:10.1007/s40135-019-00212-1 · Cited by 31
Endothelin 1-induced retinal ganglion cell death is largely mediated by JUN activation
Marola, O. J., Syc‐Mazurek, S. B., Howell, G. R., & Libby, R. T. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02990-0 · Cited by 32
Self-citationImmunomodulatory and Antioxidant Drugs in Glaucoma Treatment
Buonfiglio, F., Pfeiffer, N., & Gericke, A. (2023) · Pharmaceuticals · doi:10.3390/ph16091193 · Cited by 32
McGrady, N. R., Minton, A. Z., Stankowska, D. L., He, S., Jefferies, H. B., & Krishnamoorthy, R. R. (2017) · BMC Neuroscience · doi:10.1186/s12868-017-0346-3 · Cited by 30
Immune Mediated Degeneration and Possible Protection in Glaucoma
Tsai, T., Reinehr, S., Maliha, A. M., & Joachim, S. C. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00931 · Cited by 30
ABCA1 Regulates IOP by Modulating Cav1/eNOS/NO Signaling Pathway
Hu, C., Niu, L., Li, L., Song, M., Zhang, Y., Lei, Y., Chen, Y., & Sun, X. (2020) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.61.5.33 · Cited by 30
Jobling, A. I., Greferath, U., Dixon, M., Quiriconi, P., Eyar, B., van Koeverden, A. K., Mills, S. A., Vessey, K. A., Bui, B. V., & Fletcher, E. L. (2025) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2025.101349 · Cited by 31
Chintalapudi, S. R., Morales-Tirado, V. M., Williams, R. W., & Jablonski, M. M. (2015) · FEBS Journal · doi:10.1111/febs.13620 · Cited by 29
Marola, O. J., Syc‐Mazurek, S. B., & Libby, R. T. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0220-4 · Cited by 29
Self-citationLiu, J., Tang, M., Harkin, K., Du, X., Luo, C., Chen, M., & Xu, H. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24618 · Cited by 29
Transcriptome networks in the mouse retina: An exon level BXD RI database.
King, R., Lu, L., Williams, R. W., & Geisert, E. E. (2015) · Europe PMC (PubMed Central) · Cited by 28
1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice
Lazzara, F., Amato, R., Platania, C. B. M., Conti, F., Chou, T.-H., Porciatti, V., Drago, F., & Bucolo, C. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02263-3 · Cited by 29
Huang, W. C., Xing, W., Ryskamp, D. A., Punzo, C., & Križaj, D. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.09.001 · Cited by 29
The complement system and diabetic retinopathy
Jiang, F., Lei, C., Chen, Y., Zhou, N., & Zhang, M. (2024) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2024.02.004 · Cited by 31
Variations inCOL15A1andCOL18A1influence age of onset of primary open angle glaucoma
Wiggs, J. L., Howell, G. R., Linkroum, K., Abdrabou, W. S., Hodges, E. C., Braine, C., Pasquale, L. R., Hannon, G. J., Haines, J. L., & John, S. W. M. (2013) · Clinical Genetics · doi:10.1111/cge.12176 · Cited by 28
Self-citationGlia: guardians, gluttons, or guides for the maintenance of neuronal connectivity?
Jebelli, J. D., Su, W., Hopkins, S., Pocock, J. M., & Garden, G. A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12711 · Cited by 28
Stokowska, A., Olsson, S., Holmegaard, L., Jood, K., Blomstrand, C., Jern, C., & Pekna, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072133 · Cited by 27
Harder, J. M., Williams, P. A., Soto, I., Foxworth, N. E., Fernandes, K. A., Freeburg, N. F., Libby, R. T., & John, S. W. M. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0705-8 · Cited by 23
Self-citationWei, M., Zhang, G., Huang, Z., Ding, X., Sun, Q., Zhang, Y., Zhu, R., Guan, H., & Ji, M. J. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02855-1 · Cited by 26
Microglia depletion leads to increased susceptibility to ocular hypertension-dependent glaucoma
Diemler, C. A., MacLean, M., Heuer, S. E., Hewes, A. A., Marola, O. J., Libby, R. T., & Howell, G. R. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1396443 · Cited by 26
Self-citationMazumder, A. G., Julé, A. M., Cullen, P. F., & Sun, D. (2022) · iScience · doi:10.1016/j.isci.2022.105568 · Cited by 26
Pazos, M., Yang, H., Gardiner, S. K., Cepurna, W. O., Johnson, E. C., Morrison, J. C., & Burgoyne, C. F. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.10.014 · Cited by 26
Differential Gene Expression in GlaucomaPreprint
Jakobs, T. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a020636 · Cited by 26
Complement in animal development: Unexpected roles of a highly conserved pathway
Leslie, J. D., & Mayor, R. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.04.005 · Cited by 25
Ding, Q. J., Cook, A. C., Dumitrescu, A. V., & Kuehn, M. H. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10442 · Cited by 25
Advances in Glaucoma Treatment and Management: Neurotrophic Agents
Chader, G. J. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9483n · Cited by 25
Therapeutic targeting of the complement system in ocular disease
Rathi, S., Hasan, R., Ueffing, M., & Clark, S. J. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103757 · Cited by 24
Microglia in retinal diseases: From pathogenesis towards therapeutic strategies
Xiao, R., Huang, X., Gao, S., Duan, J., Zhang, Y., & Zhang, M. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116550 · Cited by 28
Kamat, S. S., Gregory, M. S., & Pasquale, L. R. (2016) · Seminars in Ophthalmology · doi:10.3109/08820538.2015.1114858 · Cited by 24
Complement component 3 (C3) expression in the hippocampus after excitotoxic injury: role of C/EBPβ
Hernández-Encinas, E., Morante, D. A., Morales-Garcia, J. A., Giné, E., Sanz-SanCristóbal, M., Santos, Á., & Pérez‐Castillo, A. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0742-0 · Cited by 24
Decorin—An Antagonist of TGF-β in Astrocytes of the Optic Nerve
Schneider, M., Dillinger, A. E., Ohlmann, A., Iozzo, R. V., & Fuchshofer, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147660 · Cited by 24
Lee, S. H., Jung, J. H., Park, T. K., Moon, C., Han, K., Lee, J., Lee, H. K., Ji, Y. W., & Kim, C. Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-05273-0 · Cited by 23
Astrocytes in the Optic Nerve Are Heterogeneous in Their Reactivity to Glaucomatous Injury
Zhu, Y., Wang, R., Pappas, A. C., Seifert, P. A., Savol, A. J., Sadreyev, R. I., Sun, D., & Jakobs, T. (2023) · Cells · doi:10.3390/cells12172131 · Cited by 23
Li, G., Farsiu, S., Qiu, J., Dixon, A., Song, C., McKinnon, S. J., Yuan, F., González, P., & Stamer, W. D. (2014) · PubMed Central · Cited by 23
Reinholdt, L. G., Howell, G. R., Czechanski, A., Macalinao, D. G., MacNicoll, K. H., Lin, C., Donahue, L. R., & John, S. W. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050081 · Cited by 22
Self-citationEndothelin-2 Injures the Blood–Retinal Barrier and Macroglial Müller Cells
Alrashdi, S. F., Deliyanti, D., Talia, D. M., & Wilkinson‐Berka, J. L. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.11.009 · Cited by 24
A framework to explore the visual brain in glaucoma with lessons from models and man
Yücel, Y. H., & Gupta, N. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.07.004 · Cited by 22
Vascular Inflammation Risk Factors in Retinal Disease
Soto, I., Krebs, M. P., Reagan, A. M., & Howell, G. R. (2019) · Annual Review of Vision Science · doi:10.1146/annurev-vision-091517-034416 · Cited by 24
Self-citationArfuzir, N. N. N., Agarwal, R., Iezhitsa, I. N., Agarwal, P., & Ismail, N. M. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.107996 · Cited by 22
Cytokine and Complement Response in the Glaucomatous βB1-CTGF Mouse Model
Reinehr, S., Doerner, J. D., Mueller‐Buehl, A. M., Koch, D. C., Fuchshofer, R., Dick, H. B., & Joachim, S. C. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.718087 · Cited by 23
Fan, X., Ying, Y., Zhai, R., Sheng, Q., Sun, Y., Xu, H., & Kong, X. (2022) · Annals of Translational Medicine · doi:10.21037/atm-21-5695 · Cited by 22
Microglia: Friends or Foes in Glaucoma? A Developmental Perspective
Ahmad, I., & Subramani, M. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac077 · Cited by 22
Vascular derived endothelin receptor A controls endothelin-induced retinal ganglion cell death
Marola, O. J., Howell, G. R., & Libby, R. T. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00985-8 · Cited by 22
Self-citationLambert, W. S., Pasini, S., Collyer, J. W., Formichella, C. R., Ghose, P., Carlson, B. J., & Calkins, D. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-65374-6 · Cited by 21
Restoring AIBP expression in the retina provides neuroprotection in glaucoma
Ju, W., Keun-young Kim, A., Bastola, T., Shen, Z., Choi, S., Perkins, G. A., Hwang, S., Kim, J., Kwon, J.-W., Poudel, M., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.05.009 · Cited by 19
Johnson, E. C., Cepurna, W. O., Choi, D., Choe, T. E., & Morrison, J. C. (2014) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-15094 · Cited by 21
Vitamin C protects retinal ganglion cells via SPP1 in glaucoma and after optic nerve damage
Li, S., & Jakobs, T. (2023) · Life Science Alliance · doi:10.26508/lsa.202301976 · Cited by 22
Mavlyutov, T. A., Myrah, J. J., Chauhan, A. K., Liu, Y., & McDowell, C. M. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00800-y · Cited by 20
Using BXD mouse strains in vision research: A systems genetics approach.
Geisert, E. E., & Williams, R. W. (2020) · PubMed Central · Cited by 20
Astrocyte Immune Functions and Glaucoma
Shinozaki, Y., Kashiwagi, K., & Koizumi, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032747 · Cited by 23
Endothelin-Mediated Changes in Gene Expression in Isolated Purified Rat Retinal Ganglion Cells
He, S., Park, Y. H., Yorio, T., & Krishnamoorthy, R. R. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16569 · Cited by 20
He, S., Minton, A. Z., Ma, H.-Y., Stankowska, D. L., Sun, X., & Krishnamoorthy, R. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079183 · Cited by 19
Genetic Networks in Mouse Retinal Ganglion Cells
Struebing, F. L., Lee, R. K., Williams, R. W., & Geisert, E. E. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00169 · Cited by 19
Park, Y. H., Snook, J. D., Ostrin, E. J., Kim, S., Chen, R., & Frankfort, B. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-39141-1 · Cited by 19
A broad perspective on the molecular regulation of retinal ganglion cell degeneration in glaucoma
Tezel, G. (2020) · Progress in brain research · doi:10.1016/bs.pbr.2020.05.027 · Cited by 19
Involvement of EphB/Ephrin-B Signaling in Axonal Survival in Mouse Experimental Glaucoma
Fu, C. T., & Sretavan, D. W. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8546 · Cited by 19
The effect of postmortem time on the RNA quality of human ocular tissues.
Kim, B.-J., Sprehe, N., Morganti, A., Wordinger, R. J., & Clark, A. F. (2013) · Europe PMC (PubMed Central) · Cited by 19
Self-citationAlrashdi, S. F., Deliyanti, D., & Wilkinson‐Berka, J. L. (2018) · Experimental Eye Research · doi:10.1016/j.exer.2018.06.025 · Cited by 18
Sato, K., Ohno‐Oishi, M., Yoshida, M., Sato, T., Aizawa, T., Sasaki, Y., Maekawa, S., Ishikawa, M., Omodaka, K., Kawano, C., et al. (2023) · Glia · doi:10.1002/glia.24442 · Cited by 21
Mazumder, A. G., Julé, A. M., & Sun, D. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00658-9 · Cited by 20
Luo, H., Chen, Y., Ye, Z., Sun, X., Shi, Y., Luo, Q., Gong, B., Shuai, P., Yang, J., Zhou, Y., et al. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16741 · Cited by 18
Norrin protects optic nerve axons from degeneration in a mouse model of glaucoma
Leopold, S., Zeilbeck, L. F., Weber, G. R., Seitz, R., Bösl, M. R., Jägle, H., Fuchshofer, R., Tamm, E. R., & Ohlmann, A. (2017) · Scientific Reports · doi:10.1038/s41598-017-14423-8 · Cited by 18
Inflammatory Ocular Diseases and Sphingolipid Signaling
Grambergs, R. C., Mondal, K., & Mandal, N. A. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-21162-2_8 · Cited by 20
Graham, L. C., Kocalis, H. E., Soto, I., & Howell, G. R. (2020) · eNeuro · doi:10.1523/eneuro.0057-20.2020 · Cited by 19
Self-citationYBR/EiJ mice: a new model of glaucoma caused by genes on chromosomes 4 and 17
Nair, K. S., Cosma, M., Raghupathy, N., Sellarole, M. A., Tolman, N. G., de Vries, W. N., Smith, R. S., & John, S. W. M. (2016) · Disease Models & Mechanisms · doi:10.1242/dmm.024307 · Cited by 17
Self-citationMueller, B., Dorota, L., & Raghu, R. (2011) · InTech eBooks · doi:10.5772/18465 · Cited by 15
Reichenbach, A., & Bringmann, A. (2015) · Colloquium Series on Neuroglia in Biology and Medicine From Physiology to Disease · doi:10.4199/c00122ed1v01y201412ngl003 · Cited by 18
C1q as a target molecule to treat human disease: What do mouse studies teach us?
Schulz, K., & Trendelenburg, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.958273 · Cited by 17
Vashishtha, A., Maina, S., Altman, J., Jones, G., Lee, T. J., Bollinger, K. E., Ulrich, L., Töteberg‐Harms, M., Estes, A. J., Zhi, W., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13091400 · Cited by 17
Li, S., Li, D., Shao, M., Cao, W., & Sun, X. (2018) · Journal of Glaucoma · doi:10.1097/ijg.0000000000001014 · Cited by 16
The role of aquaporin-4 in optic nerve head astrocytes in experimental glaucoma
Kimball, E. C., Schaub, J. A., Quillen, S. E., Keuthan, C. J., Pease, M. E., Korneva, A., & Quigley, H. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0244123 · Cited by 15
Changes in gene expression associated with retinal degeneration in the rd3 mouse.
Cheng, C. L., & Molday, R. S. (2013) · Europe PMC (PubMed Central) · Cited by 16
Tools and resources for analyzing gene expression changes in glaucomatous neurodegeneration
Nickells, R. W., & Pelzel, H. R. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.05.009 · Cited by 16
Tribble, J. R., Wong, V. H. Y., Stuart, K. V., Chidlow, G., Nicol, A., Rombaut, A., Rabiolo, A., Hoang, A., Lee, P. Y., Rutigliani, C., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102127 · Cited by 18
Keuthan, C. J., Schaub, J. A., Wei, M., Fang, W., Quillen, S. E., Kimball, E., Johnson, T. V., Ji, H., Zack, D. J., & Quigley, H. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813719 · Cited by 21
Complement expression in the retina is not influenced by short-term pressure elevation.
Astafurov, K. V., Dong, C. Q., Panagis, L., Kamthan, G., Ren, L., Rozenboym, A. V., Perera, T. D., Coplan, J. D., & Danias, J. (2014) · Europe PMC (PubMed Central) · Cited by 15
Regal, J. F., Lund, J. M., Wing, C. R., Root, K. M., McCutcheon, L., Bemis, L., Gilbert, J. S., & Fleming, S. D. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.06.015 · Cited by 15
Loss of Retinogeniculate Synaptic Function in the DBA/2J Mouse Model of Glaucoma
SMITH, J., Zhang, K. Y., Sladek, A. L., Thompson, J., Bierlein, E. R., Bhandari, A., & Hook, M. J. V. (2022) · eNeuro · doi:10.1523/eneuro.0421-22.2022 · Cited by 15
Insight into astrocyte activation after optic nerve injury
Yang, X., Huang, G., Feng, D., & Chen, K. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23487 · Cited by 15
Retinal degenerative diseases: Complement system-microglia crosstalk
Gao, J., Wang, W., & Mo, Y. (2025) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2025.08.005 · Cited by 14
Immunological and molecular basics of the primary open angle glaucoma pathomechanism
Samelska, K., Zaleska-Żmijewska, A., Bałan, B. J., Grąbczewski, A., Szaflik, J. P., Kubiak, A. J., & Skopiński, P. (2021) · Central European Journal of Immunology · doi:10.5114/ceji.2021.104328 · Cited by 14
Transcriptional control of retinal ganglion cell death after axonal injury
Syc‐Mazurek, S. B., Yang, H. S., Marola, O. J., Howell, G. R., & Libby, R. T. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04666-3 · Cited by 15
Self-citationDifferential Effects of C1qa Ablation on Glaucomatous Damage in Two Sexes in DBA/2NNia Mice
Kumari, R., Astafurov, K. V., Genis, A., & Danias, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142199 · Cited by 14
Reinhard, J., Wiemann, S., Joachim, S. C., Palmhof, M., Woestmann, J., Denecke, B., Wang, Y., Downey, G. P., & Faissner, A. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1376-2 · Cited by 13
Hass, D. T., & Barnstable, C. J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00201 · Cited by 15
Retinoprotective Effect of 2-Ethyl-3-hydroxy-6-methylpyridine Nicotinate
Пересыпкина, А. А., Pazhinsky, A. L., Даниленко, Л. М., Lugovskoy, S. S., Покровский, М. В., Beskhmelnitsyna, E. A., Solovev, N. V., Победа, А. С., Корокин, М. В., Levkova, E., et al. (2020) · Biology · doi:10.3390/biology9030045 · Cited by 14
A putative silencer variant in a spontaneous canine model of retinitis pigmentosa
Kaukonen, M. K., Quintero, I. B., Mukarram, A. K., Hytönen, M. K., Holopainen, S., Wickström, K., Kyöstilä, K., Arumilli, M., Jalomäki, S., Daub, C. O., et al. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008659 · Cited by 14
Wang, G.-X., Zhang, J., Dai, Y., Xu, Q., & Zhu, Q. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.07.036 · Cited by 14
Jin, N., Sha, W., & Gao, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.741368 · Cited by 16
Mihaylova, B., Petkova, I., Rankova-Yotova, C., Dimitrova, G., Tanev, I., Ivanova, S., Tsakova, A. D., & Svinarov, D. A. (2017) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2017.1334592 · Cited by 13
Kodati, B., Stankowska, D. L., Krishnamoorthy, V. R., & Krishnamoorthy, R. R. (2021) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.62.6.13 · Cited by 13
Spurlock, M. S., An, W., Reshetnikova, G., Wen, R., Wang, H., Braha, M., Solis, G., Kurtenbach, S., Galindez, O. J., Vaccari, J. P. D. R., et al. (2023) · Cells · doi:10.3390/cells12222626 · Cited by 11
Lakshmanan, Y., Wong, F. S. Y., So, K., & Chan, H. H. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05526-8 · Cited by 13
Li, L., Qin, J., Fu, T., & Shen, J. (2019) · Documenta Ophthalmologica · doi:10.1007/s10633-019-09676-9 · Cited by 13
Li, S., Qiu, Y., Yu, J. Y., Shao, M., Li, Y., Cao, W., & Sun, X. (2022) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2021-320541 · Cited by 11
The use of Nicotinamide and Nicotinamide riboside as an adjunct therapy in the treatment of glaucoma
Silva, S. G. N. E., Occhiutto, M. L., & Costa, V. P. (2023) · European Journal of Ophthalmology · doi:10.1177/11206721231161101 · Cited by 14
Nano-enhanced Optical Gene Delivery to Retinal Degenerated Mice
Batabyal, S., Gajjeraman, S., Bhattacharya, S., Wright, W. W., & Mohanty, S. K. (2019) · Current Gene Therapy · doi:10.2174/1566523219666191017114044 · Cited by 13
Aydın, R., Barış, M. E., Engin, C. D., Al‐Aswad, L. A., Blumberg, D. M., Cioffi, G. A., Liebmann, J. M., Tezel, T. H., & Tezel, G. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247401 · Cited by 13
Multivariate Longitudinal Modeling of Macular Ganglion Cell Complex
Mohammadzadeh, V., Su, E., Shi, L., Coleman, A. L., Law, S. K., Caprioli, J., Weiss, R. E., & Nouri‐Mahdavi, K. (2022) · Ophthalmology Science · doi:10.1016/j.xops.2022.100187 · Cited by 12
Calton, M. A., Lee, D. C., Sundaresan, S., Mendus, D., Leu, R. K., Wangsawihardja, F., Johnson, K. R., & Mustapha, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094549 · Cited by 12
Metadata
- Authors
- Howell, G. R., Macalinao, D. G., Sousa, G. L., Walden, M., Soto, I., Kneeland, S. C., Barbay, J. M., King, B. L., Marchant, J. K., Hibbs, M., Stevens, B., Barres, B. A., Clark, A. F., Libby, R. T., & John, S. W. M.
- Affiliations
- Howard Hughes Medical Institute (US)
- Jackson Laboratory (US)
- Mount Desert Island Biological Laboratory (US)
- Tufts University (US)
- Harvard University (US)
- Stanford University (US)
- University of North Texas Health Science Center (US)
- University of Rochester (US)
- Corresponding author
- John, Simon W.M.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2011-04-01
- Volume
- 121
- Issue
- 4
- Pages
- 1429-1444
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3069778
- OpenAlex
- W1983740408
- Cited by
- 473
- References
- 77
- Citations by year
- 2026: 25 · 2025: 28 · 2024: 20 · 2023: 46 · 2022: 43 · 2021: 34 · 2020: 39 · 2019: 26 · 2018: 24 · 2017: 33 · 2016: 29 · 2015: 35 · 2014: 24 · 2013: 28 · 2012: 28
- FWCI
- 26.40
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- American Health Assistance Foundation
- Research to Prevent Blindness
- National Institutes of Health (NIH T32, EY011721)
- National Eye Institute (EY018606, R29EY011721, R01EY018606, R01EY011721, EY011721, F32EY014515)
- National Institute of Neurological Disorders and Stroke (T32 NS51112-05, T32NS051112)
- Topics
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
- Keywords
- glaucoma, early-stage disease, complement system, endothelin system, endothelin receptor antagonism, bosentan, C1QA, optic nerve head, retina, microglia/macrophages, vascular dysfunction, disease progression, therapeutic target, DBA/2J mice
- MeSH terms
- Bosentan, Animals, Disease Models, Animal, Female, Glaucoma, Humans, Mice, Inbred DBA, Mice, Mutant Strains, Optic Nerve, Retina, Sulfonamides, Signal Transduction, Up-Regulation, Complement C1q, Cluster Analysis, Endothelin-2, Gene Expression Profiling, Mice, Endothelin Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review